Wuhan Keqian Biology Co.,Ltd

SHSE:688526 Voorraadrapport

Marktkapitalisatie: CN¥6.7b

Wuhan Keqian BiologyLtd Toekomstige groei

Future criteriumcontroles 4/6

Wuhan Keqian BiologyLtd is forecast to grow earnings and revenue by 25.3% and 21.4% per annum respectively. EPS is expected to grow by 25.3% per annum. Return on equity is forecast to be 11.9% in 3 years.

Belangrijke informatie

25.3%

Groei van de winst

25.3%

Groei van de winst per aandeel

Pharmaceuticals winstgroei19.3%
Inkomstengroei21.4%
Toekomstig rendement op eigen vermogen11.9%
Dekking van analisten

Good

Laatst bijgewerkt31 Oct 2024

Recente toekomstige groei-updates

Earnings Miss: Wuhan Keqian Biology Co.,Ltd Missed EPS By 25% And Analysts Are Revising Their Forecasts

Apr 03
Earnings Miss: Wuhan Keqian Biology Co.,Ltd Missed EPS By 25% And Analysts Are Revising Their Forecasts

Recent updates

The Market Lifts Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Shares 38% But It Can Do More

Oct 09
The Market Lifts Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Shares 38% But It Can Do More

These 4 Measures Indicate That Wuhan Keqian BiologyLtd (SHSE:688526) Is Using Debt Reasonably Well

Sep 26
These 4 Measures Indicate That Wuhan Keqian BiologyLtd (SHSE:688526) Is Using Debt Reasonably Well

Investors Continue Waiting On Sidelines For Wuhan Keqian Biology Co.,Ltd (SHSE:688526)

Aug 20
Investors Continue Waiting On Sidelines For Wuhan Keqian Biology Co.,Ltd (SHSE:688526)

We Think Wuhan Keqian BiologyLtd (SHSE:688526) Can Stay On Top Of Its Debt

Jun 26
We Think Wuhan Keqian BiologyLtd (SHSE:688526) Can Stay On Top Of Its Debt

Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Stock Rockets 25% But Many Are Still Ignoring The Company

Apr 08
Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Stock Rockets 25% But Many Are Still Ignoring The Company

Analysts Are More Bearish On Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Than They Used To Be

Apr 05
Analysts Are More Bearish On Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Than They Used To Be

Earnings Miss: Wuhan Keqian Biology Co.,Ltd Missed EPS By 25% And Analysts Are Revising Their Forecasts

Apr 03
Earnings Miss: Wuhan Keqian Biology Co.,Ltd Missed EPS By 25% And Analysts Are Revising Their Forecasts

Wuhan Keqian BiologyLtd (SHSE:688526) Has A Rock Solid Balance Sheet

Mar 20
Wuhan Keqian BiologyLtd (SHSE:688526) Has A Rock Solid Balance Sheet

Winst- en omzetgroeiprognoses

SHSE:688526 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CNY Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20261,5646074606476
12/31/20251,3515353995757
12/31/20241,1514484574927
9/30/2024902299289365N/A
6/30/2024933309385478N/A
3/31/2024989348398493N/A
12/31/20231,064396434538N/A
9/30/20231,142484447538N/A
6/30/20231,139490374460N/A
3/31/20231,078454394495N/A
12/31/20221,001410321424N/A
9/30/20221,014468240389N/A
6/30/2022952444238438N/A
3/31/2022987493109389N/A
12/31/20211,103571157531N/A
9/30/20211,015514185515N/A
6/30/20211,033551261562N/A
3/31/2021987524336546N/A
12/31/2020843448289400N/A
9/30/2020723371260387N/A
6/30/202057627180194N/A
3/31/202053925891220N/A
12/31/201950824317155N/A
12/31/2018735389320352N/A
12/31/2017633320N/A338N/A
12/31/2016390186N/A221N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: 688526's forecast earnings growth (25.3% per year) is above the savings rate (2.9%).

Winst versus markt: 688526's earnings (25.3% per year) are forecast to grow slower than the CN market (25.8% per year).

Hoge groeiwinsten: 688526's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: 688526's revenue (21.4% per year) is forecast to grow faster than the CN market (14% per year).

Hoge groei-inkomsten: 688526's revenue (21.4% per year) is forecast to grow faster than 20% per year.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: 688526's Return on Equity is forecast to be low in 3 years time (11.9%).


Ontdek groeibedrijven